OptimizeRx (OPRX) Insider Trading & Ownership $8.66 +0.28 (+3.34%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$8.68 +0.03 (+0.29%) As of 04/25/2025 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock OptimizeRx (NASDAQ:OPRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.10%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$2.54 MNumber OfInsiders Selling(Last 12 Months)0 Get OPRX Insider Trade Alerts Want to know when executives and insiders are buying or selling OptimizeRx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address OPRX Insider Buying and Selling by Quarter OptimizeRx Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/14/2025James Paul LangDirectorBuy321,408$7.60$2,442,700.80 12/12/2024William J FebboCEOBuy20,000$5.01$100,200.00 (Data available from 1/1/2013 forward) OPRX Insider Trading Activity - Frequently Asked Questions Who is on OptimizeRx's Insider Roster? The list of insiders at OptimizeRx includes Edward Stelmakh, Ellen O'connor Vos, James Paul Lang, Marion Odence-Ford, Stephen L Silvestro, and William J Febbo. Learn more on insiders at OPRX. What percentage of OptimizeRx stock is owned by insiders? 6.10% of OptimizeRx stock is owned by insiders. Learn more on OPRX's insider holdings. Which OptimizeRx insiders have been buying company stock? The following insiders have purchased OPRX shares in the last 24 months: James Paul Lang ($2,442,700.80), and William J Febbo ($100,200.00). How much insider buying is happening at OptimizeRx? Insiders have purchased a total of 341,408 OPRX shares in the last 24 months for a total of $2,542,900.80 bought. Which OptimizeRx insiders have been selling company stock? The following insider sold OPRX shares in the last 24 months: Marion Odence-Ford ($60,760.00). How much insider selling is happening at OptimizeRx? Insiders have sold a total of 4,000 OptimizeRx shares in the last 24 months for a total of $60,760.00 sold. OptimizeRx Key ExecutivesMr. William J. Febbo (Age 55)CEO & Director Compensation: $863.15k1 recent tradesMr. Stephen L. Silvestro (Age 46)President Compensation: $591.62kMr. Edward Stelmakh C.M.A. (Age 58)M.B.A., CFO & COO Compensation: $626.74kMr. Andrew Jacob D'SilvaSenior Vice President of Corporate Finance More Insider Trading Tools from MarketBeat Related Companies Accolade Insider Selling Willdan Group Insider Selling Priority Technology Insider Selling Thryv Insider Selling MediaAlpha Insider Selling Montrose Environmental Group Insider Selling Enviri Insider Selling Repay Insider Selling Advantage Solutions Insider Selling Absci Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market Sentiment This page (NASDAQ:OPRX) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptimizeRx Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share OptimizeRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OPRX Stock Free OPRX Stock Alerts